1200 Pharma utilizes medicinal chemistry technologies to streamline pre-clinical drug discovery processes and reduce clinical trial timelines. By enhancing the efficiency of drug development, the company addresses the lengthy and costly nature of bringing new therapeutics to market.

Actuate Therapeutics develops elraglusib, a GSK-3 inhibitor that targets multiple molecular pathways to slow, stop, or shrink tumors in patients with hard-to-treat cancers. This approach aims to enhance anti-tumor immunity while minimizing adverse effects associated with conventional therapies.

This company manufactures specialty metallic parts using novel metal alloy technologies to improve machine performance. Their parts, including lightweight, precision gearboxes, enhance durability, elasticity, and wear for various industries.

Avvio Medical provides an office‑based lithotripsy system that uses low‑pressure ultrasound and calcium‑targeted microbubbles to fragment kidney and ureteral stones without anesthesia or stents. The portable console integrates real‑time imaging, automated safety interlocks, and a dedicated CPT code, enabling urologists and ambulatory surgery centers to perform same‑day, cost‑effective stone removal in standard examination rooms.

Axial Therapeutics is developing gut-restricted small molecule therapies targeting the gut-brain axis to treat conditions such as irritability associated with autism spectrum disorder and Parkinson’s disease. Their lead candidate, AB-2004, is currently undergoing a Phase 2 clinical trial to evaluate its efficacy in addressing these neurological disorders.

Behavioral Signals develops Emotion Cognitive AI technology that analyzes voice data to assess emotional states and predict customer intent. This enables organizations to optimize agent-customer interactions, resulting in measurable improvements such as a 20% increase in agent productivity and enhanced customer satisfaction.

CellMidi develops PLUS CAR T technology that utilizes gene-edited immune cells to enhance CAR T cell therapy outcomes in solid tumors. This approach targets immune suppression within the tumor microenvironment, providing a cost-effective treatment option for patients with previously untreatable cancers.

Chimera develops drug-responsive gene regulators to enhance engineered T-cell therapies, enabling precise targeting of tumor cells while minimizing systemic toxicity. This approach addresses the limitations of conventional cell therapies, which often fail due to immunosuppressive tumor environments and uncontrolled cell behavior.

Clear is a mobile application designed for users to meticulously track their daily skincare routines and product usage. The platform allows individuals to maintain a detailed diary of their regimen, fostering consistency and progress monitoring for various skin concerns. Additionally, Clear incorporates a community feature where users can share product ratings and experiences in a supportive environment.

DEARhealth provides a digital health platform that continuously monitors real-time patient data and delivers personalized care recommendations through its clinical decision support system. This technology enhances the management of chronic conditions by improving patient engagement, reducing hospital visits by 33-50%, and lowering healthcare costs by 12% through optimized treatment pathways.

Delpor develops long-acting injectable therapies for chronic central nervous system disorders, using its proprietary PROZOR and NANOPOR delivery platforms to enable once-yearly dosing. The approach aims to improve patient adherence in conditions such as schizophrenia and opioid use disorder.

E INC enhances the automotive purchasing process by providing a digital platform that streamlines wholesale and retail transactions through advanced technology and data analytics. This approach addresses inefficiencies in the automotive ecosystem, enabling faster and more flexible business operations for dealers and consumers.

GuRu Wireless provides wireless power transfer solutions using proprietary mmWave and Smart RF Lensing technology, enabling the transmission of power at 24GHz over longer distances with higher efficiency. This technology addresses the limitations of traditional wired and battery-powered systems, facilitating new applications in sectors where conventional power delivery is impractical.

Holoclara develops immunotherapy treatments for autoimmune disorders using nematode-derived molecules. The company aims to provide relief for millions suffering from debilitating diseases by targeting the underlying immune responses associated with these conditions.

INIA develops home-use IPL (Intense Pulsed Light) devices for targeted hair removal, effectively addressing the challenges of stubborn coarse hair in sensitive areas. Their products also include a wireless red light therapy mask and microcurrent facial devices, providing non-invasive solutions for skin rejuvenation and anti-aging treatments.

Labs develops human-enhancement technologies that utilize artificial intelligence, immersive realities, and consumer-wearables to foster community engagement and improve individual capabilities. The company addresses the need for interconnected social experiences and sustainable practices by providing tools that empower users to learn, create, and collaborate effectively.

LifeSprout develops a platform of soft tissue replacement products that mimic the structure and function of human tissues, utilizing advanced materials science techniques. These products address soft tissue loss due to aging, cancer, and metabolic diseases, offering patients minimal downtime and improved aesthetic and functional outcomes.

Linnaeus Therapeutics is developing small molecule agents for cancer treatment, informed by clinical observations that highlight the impact of gender and pregnancy history on cancer incidence and survival rates. The company focuses on identifying new therapeutic targets to enhance treatment efficacy for various cancers, including melanoma and pancreatic ductal adenocarcinoma.

Provides a shared progress tracking platform for coaches and clients, enabling clients to log actions, track goals, and maintain accountability between sessions. Coaches gain measurable insights into client progress and engagement through customizable logs, reminders, and real-time feedback tools, improving the effectiveness of their practice.

Mattiq develops advanced electrochemical systems to produce chemicals and fuels without fossil fuel inputs, eliminating the green premium. Their modular, industrial-scale processes enable economically competitive decarbonization across a broad spectrum of chemicals, plastics, and fuels.

MemVerge offers a Memory-Converged Infrastructure system utilizing proprietary DMO technology to optimize GPU workloads for Generative AI applications. Their Memory Machine™ suite enables organizations to reduce cloud costs by up to 90% through transparent checkpointing and efficient GPU scheduling, while enhancing GPU utilization and accelerating AI workloads.

O is developing an IoT device that visualizes the human circadian clock to enhance individual and organizational performance through data-driven insights. The platform provides actionable recommendations based on sleep data, addressing productivity issues and mental health risks within teams.

OppDoor provides technology-enabled services that enhance online selling efficiency on marketplaces like Amazon, Walmart, and Etsy through the integration of AI and data analytics. The company addresses the challenges of inventory management and sales optimization, enabling sellers to increase their revenue and streamline operations.

Om provides access to massive, internally generated datasets detailing proteome-wide small molecule binding data. Researchers can programmatically query billions of protein and small molecule interaction data points to identify therapeutic opportunities instantly. The platform leverages synthetic biology and pico-scale engineering to accelerate the transition from hypothesis to launching a discovery program.